A systematic review of nineteen studies with 4375 patients, published Oct. 14, 2026, in the American Journal of Clinical Dermatology, found that tapering targeted eczema drugs often kept disease controlled better than stopping abruptly, with results varying by drug.
A systematic review of 10 observational studies found that a median of 47.8% of people with nummular eczema, which causes coin-shaped itchy patches, tested positive for at least one contact allergen, with nickel, chromate, cobalt and fragrances among the most…
In 157,966 US adults with atopic dermatitis, using a targeted therapy, almost always dupilumab, was linked to 1.6 points lower probability of hospitalization and 1.7 points lower probability of emergency visits, but higher total spending due to drug costs.